Total medical devices industry venture financing deals in Q4 2019 worth $1.87bn were announced in the US, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the code below into your website to display the chart.

The value marked an increase of 32.9% over the previous quarter and a rise of 12.05% when compared with the last four-quarter average of $1.67bn.

The US held a 63.5% share of the global medical devices industry venture financing deal value that totalled $2.94bn in Q4 2019.

In terms of deal activity, the US recorded 169 deals during Q4 2019, marking a drop of 6.1% over the previous quarter and a drop of 6.1% over the last four-quarter average.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The US medical devices industry venture financing deals in Q4 2019: Top deals

The top five medical devices industry venture financing deals accounted for 23.6% of the overall value during Q4 2019.

The combined value of the top five medical devices venture financing deals stood at $440m, against the overall value of $1.87bn recorded for the month.

The top five medical devices industry deals of Q4 2019 tracked by GlobalData were:

1) Foresite Capital Management, JS Capital Management, Merieux Developpement, MLS Capital Fund II, NanoDimension Management, Oak HC/FT Partners, Paladin Capital Group and Venrock’s $125m venture financing of Inscripta

2) The $90m venture financing of GenapSys by Foresite Capital Management

3) 3H Health Investment, Ally Bridge Group, Ascension Ventures, Bain Capital Life Sciences, Delos Capital, Incept and Rock Springs Capital Management’s $85m venture financing of Imperative Care

4) The $85m venture financing of Sonendo by ArrowMark Partners, Broadfin Capital, CVF, Essex Woodlands Management, General Atlantic, JMR Capital, Meritech Capital Partners, NeoMed Management, Orbimed Advisors, Perceptive Advisors, Redmile Group, SEB Private Equity and Security Pacific Finance

5) ArrowMark Partners, Boulder Ventures, Driehaus Capital Management, Longwood Fund Management, PBM Capital Group, Perceptive Advisors, Redmile Group, Sands Capital Management and Soleus Capital Management’s venture financing of ArcherDx for $55m.

Verdict deals analysis methodology

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.